Search…

Tonghe Pharmaceutical: the company's Agomelatine and Opipramol Active Pharmaceutical Ingredients (APIs) have obtained market access qualifications in South Korea.

22/07/2025

Tonghe Pharmaceutical announced that the company has recently received the registration certificates for the drug Agomelatine and Aripiprazole issued by the South Korean Ministry of Food and Drug Safety. This marks the qualifications for entering the South Korean market for the company's Agomelatine and Aripiprazole active pharmaceutical ingredients, which will play a positive role in further expanding the company's international market business.

Latest

1 m ago

RTX Corporation has revised its revenue forecast for 2025 from $83 billion to $84.75 billion. Sales in the Pratt & Whitney division, which provides engines for the Airbus A320neo, have increased by 12%. The division has been facing production issues in recent years and is currently conducting inspections on gear-driven fan engine components that may have defects, resulting in hundreds of planes being grounded in recent months.

1 m ago

The US Department of the Treasury has imposed sanctions on individuals and entities related to the Houthi armed group.

2 m ago

Geopolitical tension escalating has fueled strong demand for RTX company's defense products. RTX's "Patriot" missile defense system is widely used in the Ukrainian battlefield to counter missile threats. RTX's defense department saw a sales increase of 8% to $7 billion in the second quarter.

2 m ago

RTX has adjusted its earnings per share forecast for 2025 from $6.00-6.15 to $5.80-5.95. Due to delays in the production of new aircraft, airlines are extending the operational life of their older fleets, benefiting the commercial aircraft maintenance business.

3 m ago

RTX warning that if the steel and aluminum tariffs remain at 25%, the tariffs on China remain at 145%, and global reciprocal tariffs reach 10%, a trade war will result in a loss of $850 million.

See all latest